Version 5.4
Homo sapiens Protein: COL5A1
Summary
InnateDB Protein IDBP-813582.1
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol COL5A1
Protein Name collagen, type V, alpha 1
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000481360
InnateDB Gene IDBG-91757 (COL5A1)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 11 experimentally validated interaction(s) in this database.
They are also associated with 5 interaction(s) predicted by orthology.
Experimentally validated
Total 11 [view]
Protein-Protein 10 [view]
Protein-DNA 1 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 5 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005201 extracellular matrix structural constituent
Biological Process
Cellular Component
GO:0005581 collagen trimer
Protein Structure and Domains
PDB ID
InterPro IPR000885 Fibrillar collagen, C-terminal
IPR001791 Laminin G domain
IPR002181 Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain
IPR008160 Collagen triple helix repeat
IPR008985 Concanavalin A-like lectin/glucanases superfamily
PFAM PF01410
PF00054
PF02210
PF00147
PF01391
PRINTS
PIRSF
SMART SM00038
SM00210
SM00282
SM00186
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL Q9UML4
UniProt Splice Variant
Entrez Gene 1289
UniGene
RefSeq NP_001265003
HUGO HGNC:2209
OMIM 120215
CCDS CCDS75932
HPRD
IMGT
EMBL L38808
GenPept AAA79853

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca